Abilify 2 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7QFN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,986
Award facts
- Contract value 100% obligated
- $4,986.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $4,986.44 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Abilify 2 mg tablets (30-count package), with an ultimate completion date of March 9, 2026.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, Pennsylvania. Pricing is firm fixed price with no set-aside applied.
Quick answers
Who was awarded contract SPE2DR26F7QFN?
SPE2DR26F7QFN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 6, 2026.
How much is contract SPE2DR26F7QFN worth?
The government has obligated $4,986 on SPE2DR26F7QFN.
Is contract SPE2DR26F7QFN an order under another contract?
Yes. SPE2DR26F7QFN is a delivery order under SPE2DR25D7059, an indefinite delivery contract.
Was contract SPE2DR26F7QFN competed?
The extent of competition for SPE2DR26F7QFN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award